PharmEco Group of Companies

Search

RU | EN

BioJet – EN
  • About
    • General information
    • Administration
    • Pharmacovigilance
    • Business ethics
  • Production
  • Our products
  • News
  • Jobs
  • Contacts

Mishustin: 90% of Essential Medicines Should Be Produced in Russia

According to the Prime Minister, this goal will be pursued as part of the national project “New Health Preservation Technologies.”

The share of domestically produced medicines from the list of essential and vital drugs (EVDL) in Russia should increase to 90% by 2030, Russian Prime Minister Mikhail Mishustin announced.

He noted that this effort will be conducted within the framework of the national project “New Health Preservation Technologies.”

“Activities under the national project ‘New Health Preservation Technologies’ will help expand the use of biomedical technologies, regenerative medicine methods, and improve access for citizens to advanced approaches in prevention and treatment. The share of domestically produced essential and vital medicines should increase to 90%,” said the Prime Minister while addressing the National Projects Council.

In April, during a report on the government’s work in 2023, Mishustin stated that the current share of domestically produced medicines from the EVDL list stands at 80%.

Source: TASS, December 5, 2024

Current news

  • June 3, 2026

    Russia Proposes Clarifying Rules for Using Patented Medicines in Research

    A bill has been submitted to the State Duma that would allow patented medicines to…

  • June 3, 2026

    Regulator Clarifies Rules for Describing Medicines in Public Procurement

    Russia’s Ministry of Health has clarified the rules for describing medicinal products in state and…

  • June 3, 2026

    Ministry of Industry and Trade Prepares New Subsidy Mechanism for Drug Development

    Russia’s Ministry of Industry and Trade has prepared a draft resolution introducing a new procedure…

  • June 3, 2026

    Russian Health Ministry Proposes Major Changes to Pharmaceutical Manufacturing Inspections

    Russia’s Ministry of Health has submitted for public consultation a draft legislative package introducing amendments…

  • June 3, 2026

    Sirius to Launch Master’s Programs in Drug Development

    The programs will be implemented jointly with leading Russian pharmaceutical companies and research centers. Sirius…

LLC “BioJet”. all rights reserved

  • Legal information